Skip to content

A 12-week, Multi-center, Randomized, Double-blind, Placebo-Controlled Clinical Trial for the Evaluation of the Efficacy and Safety of HUN2-483 on Cognitive Function Improvement

A 12-week, Multi-center, Randomized, Double-blind, Placebo-Controlled Clinical Trial for the Evaluation of the Efficacy and Safety of HUN2-483 on Cognitive Function Improvement

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0009401
Enrollment
100
Registered
2024-05-03
Start date
2023-07-05
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : - HUN2-483 group: once a day, 2 capsules once, for 12 weeks (480 mg/day) - Placebo group: once a day, 2 capsules once, for 12 weeks

Sponsors

Huons
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Adult aged 40 to under 85 2) Koreans who can decipher Korean language 3) Participants who have mini mental state examination score of 18 to 28 4) A person who agrees to participate in this study before the start of the study and prepares a written consent form

Exclusion criteria

Exclusion criteria: 1) A person currently being treated for severe cardiovascular, respiratory, immune, gastrointestinal/hepatic and biliary systems, kidney and urology, nervous, musculoskeletal, infectious diseases and malignant tumors 2) A Persons who has neuropsychological disease such as depression (based on DSM-5), schizophrenia, alcoholism, and drug dependence 3) A person who has a disease accompanied by cognitive impairment, such as dementia (based on DSM-5) and Parkinson's disease 4) A person diagnosed with an intellectual disability

Design outcomes

Primary

MeasureTime frame
Alzheimer's Disease Assessment Scale-cognitive subscale

Secondary

MeasureTime frame
Visual C.P.T;Korean Mini-Mental Status Examination;Korean-Beck Depression Inventory-II;Stroop test;Brain-derived neurotrophic factor

Countries

Korea, Republic of

Contacts

Public ContactJayoung Goo

Konkuk University Medical Center

kjy_97@naver.com+82-2-2030-6536

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026